The demand within the global in-vitro diagnostics market is set to rise at a sturdy pace in the times to follow. It has become crucial for the healthcare industry to ensure optimal growth in multiple domains. Precise and effective diagnosis takes center stage across the healthcare industry, and several healthcare professionals (HCPs) emphasize on the need for developing resilient diagnostic technologies. In the past years, the success of diagnostic tests have defined the success of treatment lines, vindicating the relevance of various diagnostic facilities. Besides, a number of new diagnostic centers have been developed across multiple regional pockets. Therefore, the global in-vitro diagnostic market is slated to grow at a sturdy pace in the years to follow.

In this report preview, several dynamics of growth within the global in-vitro diagnostics market have been enunciated. Transparency Market Research (TMR) predicts that the global in-vitro diagnostics market would touch a value of US$89862.2 Mn by 2025-end, rising from a value of US$55000 Mn in 2016. The CAGR of the global in-vitro diagnostics market is tabulated at 5.60% over the period between 2017 and 2025. The changing dynamics of the medical and healthcare industries have emerged as a launch pad for market maturity. 

in vitro diagnostics market

Development of State-of-the-Art Diagnostic Facilities

It is legit to predict that several new diagnostic facilities would come to the fore of the healthcare sector in the times to follow. Improvement in collection and management of medical samples plays a crucial role in performing effective in-vitro diagnostics. This has led the healthcare industry to define regulations and rules for collection of blood, urine, and other samples. The success of in-vitro diagnostics has led several new diagnostic centers to explore the potential of this technology. In-vitro testing is characterised by precision and pinpoint detail. This factor has given confidence to the healthcare sector with regard to the use of in-vitro diagnostic. The revenue index of the global in-vitro diagnostic market is poised to improve in the times to come by.

Application of In-Vitro Testing in Oncology

On the basis of application, the global in-vitro diagnostics market can be segmented by - infectious disease, drug testing, oncology, autoimmune disease, and metabolic disease. The unprecedented demand for improved diagnostics in the field of oncology shall drive demand within the market. Discovery of new forms of tumours in the human body have raised concerns across the healthcare sector. Besides, the rising occurrence of known tumours amongst the masses has transcended as a challenge for the healthcare sector. Therefore, the quest of the healthcare industry to resolve the growing incidence of various types of cancers shall aid the growth of the global in-vitro diagnostic market. Furthermore, collection of samples for biopsies and other similar tests has also supported market maturity. The next few years would be crucial in understanding the direction of growth for the in-vitro diagnostic market. The revolutionary growth of the diagnostic domain shall be a gamechanger for the market vendors.

Impact of COVID-19 Pandemic on Market Expansion

The rising incidence of infectious diseases shall also play an important role in market growth. The outbreak of the COVID-19 pandemic has led to investments in new research lines for diagnostic and treatment of infectious diseases. The medical industry has tasted some success in developing resilient diagnostic technologies for COVID-19. However, there is a long way ahead for the medical and healthcare sectors. As new research lines emerge for the management of the pandemic, the global in-vitro diagnostics market would grow at a sturdy pace. Furthermore, there has been an increase in the number of cases for COVID-19. This factor has also played an underhanded role in driving demand for in-vitro diagnostic tests. Analysis of blood samples has gained relevance across several verticals of the healthcare sector.

Technologies Used for In-Vitro Diagnostics

Various technologies can be employed for performing in-vitro diagnostic tests. Some of these technologies include Molecular Diagnostics, Point of Care, Immunoassays, Whole Blood Glucose Monitoring, Clinical Chemistry, Hematology, Coagulation, Clinical Microbiology, and Hemostasis. The growing importance of point-of-care diagnostics can be attributed to the advent of digital transformation across the healthcare industry. Besides, use of whole blood glucose monitoring shall also play a vital part in driving sales across the global market. There is little contention about the importance of clinical chemistry and coagulation technologies across the domain of cardiovascular diseases.

Growth of North America Market

On the basis of geography, several new trends and opportunities have emerged in leading markets such as Asia Pacific, North America, Europe, Middle East and Africa, and South America. The use of in-vitro testing in North America has increased by a noticeable chase. This can be attributed to the steep rise in the number of COVID-19 cases across the US. Several Asia Pacific countries have also joined hands to deal with the rising incidence of various communicable and non-communicable diseases. This has given an impetus to the growth of the regional market. The marked rise in the number of cases of cancer and lung disorders shall aid market expansion in several regions.

The vendors operating in the global in-vitro diagnostic market are making deliberate efforts to educate people about the relevance of testing and sample collection. The quest of these vendors to capture new domains within the domain of healthcare shall drive demand within the global market. Some of the leading players operating in the in-vitro diagnostic market are Becton Dickinson and Company, Thermo Fisher Scientific Corporation, Sysmex Corporation, Danaher Corporation, Siemens Healthineers, Diasorin, and Biomerieux SA.

The demand within the global in-vitro diagnostics market is set to rise at a sturdy pace in the times to follow. It has become crucial for the healthcare industry to ensure optimal growth in multiple domains. Precise and effective diagnosis takes center stage across the healthcare industry, and several healthcare professionals (HCPs) emphasize on the need for developing resilient diagnostic technologies. In the past years, the success of diagnostic tests have defined the success of treatment lines, vindicating the relevance of various diagnostic facilities. Besides, a number of new diagnostic centers have been developed across multiple regional pockets. Therefore, the global in-vitro diagnostic market is slated to grow at a sturdy pace in the years to follow.

In this report preview, several dynamics of growth within the global in-vitro diagnostics market have been enunciated. Transparency Market Research (TMR) predicts that the global in-vitro diagnostics market would touch a value of US$89862.2 Mn by 2025-end, rising from a value of US$55000 Mn in 2016. The CAGR of the global in-vitro diagnostics market is tabulated at 5.60% over the period between 2017 and 2025. The changing dynamics of the medical and healthcare industries have emerged as a launch pad for market maturity. 

in vitro diagnostics market

Development of State-of-the-Art Diagnostic Facilities

It is legit to predict that several new diagnostic facilities would come to the fore of the healthcare sector in the times to follow. Improvement in collection and management of medical samples plays a crucial role in performing effective in-vitro diagnostics. This has led the healthcare industry to define regulations and rules for collection of blood, urine, and other samples. The success of in-vitro diagnostics has led several new diagnostic centers to explore the potential of this technology. In-vitro testing is characterised by precision and pinpoint detail. This factor has given confidence to the healthcare sector with regard to the use of in-vitro diagnostic. The revenue index of the global in-vitro diagnostic market is poised to improve in the times to come by.

Application of In-Vitro Testing in Oncology

On the basis of application, the global in-vitro diagnostics market can be segmented by - infectious disease, drug testing, oncology, autoimmune disease, and metabolic disease. The unprecedented demand for improved diagnostics in the field of oncology shall drive demand within the market. Discovery of new forms of tumours in the human body have raised concerns across the healthcare sector. Besides, the rising occurrence of known tumours amongst the masses has transcended as a challenge for the healthcare sector. Therefore, the quest of the healthcare industry to resolve the growing incidence of various types of cancers shall aid the growth of the global in-vitro diagnostic market. Furthermore, collection of samples for biopsies and other similar tests has also supported market maturity. The next few years would be crucial in understanding the direction of growth for the in-vitro diagnostic market. The revolutionary growth of the diagnostic domain shall be a gamechanger for the market vendors.

Impact of COVID-19 Pandemic on Market Expansion

The rising incidence of infectious diseases shall also play an important role in market growth. The outbreak of the COVID-19 pandemic has led to investments in new research lines for diagnostic and treatment of infectious diseases. The medical industry has tasted some success in developing resilient diagnostic technologies for COVID-19. However, there is a long way ahead for the medical and healthcare sectors. As new research lines emerge for the management of the pandemic, the global in-vitro diagnostics market would grow at a sturdy pace. Furthermore, there has been an increase in the number of cases for COVID-19. This factor has also played an underhanded role in driving demand for in-vitro diagnostic tests. Analysis of blood samples has gained relevance across several verticals of the healthcare sector.

Technologies Used for In-Vitro Diagnostics

Various technologies can be employed for performing in-vitro diagnostic tests. Some of these technologies include Molecular Diagnostics, Point of Care, Immunoassays, Whole Blood Glucose Monitoring, Clinical Chemistry, Hematology, Coagulation, Clinical Microbiology, and Hemostasis. The growing importance of point-of-care diagnostics can be attributed to the advent of digital transformation across the healthcare industry. Besides, use of whole blood glucose monitoring shall also play a vital part in driving sales across the global market. There is little contention about the importance of clinical chemistry and coagulation technologies across the domain of cardiovascular diseases.

Growth of North America Market

On the basis of geography, several new trends and opportunities have emerged in leading markets such as Asia Pacific, North America, Europe, Middle East and Africa, and South America. The use of in-vitro testing in North America has increased by a noticeable chase. This can be attributed to the steep rise in the number of COVID-19 cases across the US. Several Asia Pacific countries have also joined hands to deal with the rising incidence of various communicable and non-communicable diseases. This has given an impetus to the growth of the regional market. The marked rise in the number of cases of cancer and lung disorders shall aid market expansion in several regions.

The vendors operating in the global in-vitro diagnostic market are making deliberate efforts to educate people about the relevance of testing and sample collection. The quest of these vendors to capture new domains within the domain of healthcare shall drive demand within the global market. Some of the leading players operating in the in-vitro diagnostic market are Becton Dickinson and Company, Thermo Fisher Scientific Corporation, Sysmex Corporation, Danaher Corporation, Siemens Healthineers, Diasorin, and Biomerieux SA.

Global In Vitro Diagnostics Market: Overview

This report on in vitro diagnostics market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing in vitro diagnostics products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global in vitro diagnostics market with respect to the leading market segments based on major types, applications, end users, and geographies.

Global In Vitro Diagnostics Market: Key Segments

By technology type market further segmented into point of care, molecular diagnostics, immunoassays, clinical chemistry, whole blood glucose monitoring, hematology, clinical microbiology, coagulation and hemostasis, and others. On the basis of applications in vitro diagnostics market has been segmented as drug testing, infectious disease, oncology, metabolic disease, autoimmune disease, and others. Further the market has been segmented according to its end users that includes diagnostics laboratories, hospitals, academic & research centers, home care and others. Each of the market segments have been extensively analyzed based on the market related factors such as increasing adoption rate worldwide, and technological advancement, in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the in vitro diagnostics market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global in vitro diagnostics market.

Global In Vitro Diagnostics Market: Regional Outlook

Geographically, in vitro diagnostics market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, market strategy overview, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global In Vitro Diagnostics Market.

Companies Mentioned in Report

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global In Vitro Diagnostics Market. The key players operating in the in vitro diagnostics market are Abbott., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Gen-Probe Incorporated, Ortho Clinical Diagnostics, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers (a division of Siemens AG), Sysmex Corporation, Qiagen N.V., Diasorin and Thermo Fisher Scientific Corporation. The global in vitro diagnostics market is dominated only by few players such as F. Hoffmann-La Roche Ltd and Abbott that operates global market. 

The global In Vitro Diagnostics Market is segmented as follows:

Technology

  • Point of Care
  • Molecular Diagnostics
    • Polymerase Chain Reaction(PCR)
    • Isothermal Nucleic Acid Amplification Technology
    • Microarray
    • Hybridization
    • DNA Sequencing and Next Generation Sequencing
    • Other MDX Technologies
  • Immunoassay
    • Enzyme-Linked Immunosorbent Assays (ELISA)
    • Radioimmunoassay (RIA)
    • Enzyme-Linked Immunospot (ELIspot) Assay
    • Rapid Tests
    • Other Immunoassay Techniques
  • Clinical Chemistry
    • Basic Metabolic Profile
    • Electrolyte Panel
    • Liver Panel
    • Lipid Panel
    • Renal Panel
    • Thyroid Function Panel
    • Specialty Chemical Tests
  • Whole Blood Glucose Monitoring
  • Hematology
  • Clinical Microbiology
  • Coagulation and Hemostasis
  • Others

Application

  • Drug Testing
  • Infectious Disease
  • Oncology
  • Metabolic Disease
  • Autoimmune Disease
  • Others

End User

  • Diagnostics Laboratories
  • Hospitals
  • Academic & Research Centers
  • Home Care
  • Others

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

In Vitro Diagnostic Tests

Buy Now